Drug recall D-1302-2022

Class II Terminated reported Aug 10, 2022

Product

Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA; NDC 52544-691-30.

Reason for recall

Failed Dissolution Specifications: below specification limits for dissolution.

Lots and codes

Lot 1411593A, Exp 09/22

Recall details

Recalling firm
Teva Pharmaceuticals USA Inc, Parsippany, NJ
Quantity
8022 bottles
Distribution
Nationwide in the USA and Puerto Rico
Type
Voluntary: Firm initiated
Recall initiated
July 21, 2022
Terminated
April 18, 2023

Related products